United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
372.89
+5.53 (1.51%)
Nov 22, 2024, 4:00 PM EST - Market closed
United Therapeutics Employees
United Therapeutics had 1,168 employees as of December 31, 2023. The number of employees increased by 183 or 18.58% compared to the previous year.
Employees
1,168
Change (1Y)
183
Growth (1Y)
18.58%
Revenue / Employee
$2,359,760
Profits / Employee
$951,113
Market Cap
16.65B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Baxter International | 60,000 |
Quest Diagnostics | 48,000 |
ICON Public Limited Company | 41,100 |
Viatris | 38,000 |
Align Technology | 21,610 |
Molina Healthcare | 18,000 |
Avantor | 7,570 |
Hologic | 6,990 |
UTHR News
- 8 days ago - United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy - Seeking Alpha
- 9 days ago - United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom - Seeking Alpha
- 9 days ago - United Therapeutics: One To Believe In Despite Competitive Threats - Seeking Alpha
- 18 days ago - United Therapeutics Corporation to Present at the UBS Global Healthcare Conference - Business Wire
- 24 days ago - United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - United Therapeutics Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service - Business Wire
- 4 weeks ago - United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024 - Business Wire